Stay updated on GSK2857916 Two Doses in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.

Latest updates to the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page
- Check2 days agoChange DetectedUpdated the page’s footer/version marker to a newer release and added entries under the “related topics” section (e.g., MedlinePlus Genetics). This reflects supplementary site metadata/navigation rather than substantive changes to the clinical trial information.SummaryDifference0.1%

- Check9 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2.SummaryDifference0.0%

- Check16 days agoNo Change Detected
- Check38 days agoChange DetectedRevision updated from v3.4.3 to v3.5.0.SummaryDifference0.0%

- Check45 days agoChange DetectedRevision tag updated from v3.4.2 to v3.4.3.SummaryDifference0.0%

- Check60 days agoChange DetectedRemoved the 'Multiple myeloma' condition label and the related topics section, including the 'MedlinePlus Genetics' link.SummaryDifference0.1%

- Check74 days agoChange DetectedAdded core topics 'Multiple myeloma' and 'MedlinePlus Genetics' and updated the page to Revision v3.4.2. Removed the government-funding lapse notice and the previous revision tag v3.4.1.SummaryDifference0.3%

Stay in the know with updates to GSK2857916 Two Doses in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GSK2857916 Two Doses in Multiple Myeloma Clinical Trial page.